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The synthesis of novel d-sultam scaffolds utilizing one-pot, three-component reactions of 1,3-dicarbonyl
compounds, primary aliphatic amines and substituted styrenesulfonyl chlorides is reported. A variety of
six-membered sultams are obtained in moderate to good yields presumably via N-sulfonylation
—intramolecular Michael addition sequences.
























Figure 1. Biologically active six-membered sultams.Sulfonamides have a rich chemical and biological history and
are an important class of compounds in drug discovery due to their
extensive chemical and biological activities.1 Signiﬁcant interest
has been directed toward cyclic sulfonamides, also known as sul-
tams. Although not found in nature, these compounds demonstrate
a wide spectrum of activitiy.2 Examples include the antiepileptic
agent sulthiame,3 the COX-2 inhibitor ampiroxicam,4 and benzodi-
thiazine dioxides displaying anti-HIV-1 activity5 (Fig. 1). As chem-
ically important materials, sultams have been utilized as efﬁcient
chiral auxiliaries and reagents.6
Sultams have traditionally been synthesized via cyclization pro-
tocols such as the Pictet–Spengler,2a and methods including Fri-
edel–Crafts,7 dianion alkylation,8 cyclization of aminosulfonyl
chlorides,9 [3+2] cycloadditions,10 and Diels–Alder reactions.11 Re-
cently, a number of transition metal catalyzed approaches to sul-
tams have been reported, including the use of Pd,12 Au,13 Cu,14
and Rh.15
Herein, we report the one-pot, three-component synthesis of
novel d-sultams via reaction of commercially available primary ali-
phatic amines and 1,3-dicarbonyl compounds with readily pre-
pared substituted styrenesulfonyl chlorides.16
In a model experiment enaminone 3a, obtained from the reac-
tion of primary amine 1a with b-ketoester 2a, was treated with
styrenesulfonyl chloride (4a) in CH2Cl2 at room temperature. Thell rights reserved.
di).reaction proceeded smoothly and was complete within 12 h,
affording the sultam 5a in 76% yield (Scheme 1a).
Further studies revealed that 5a could be prepared via a one-pot
reaction. This involved successive addition of amine 1a and sty-
renesulfonyl chloride (4a) to a solution of b-ketoester 2a in CH2Cl2
at room temperature (Scheme 1b).17 Therefore, enaminone 3amay
be implicated in this three-component reaction. The structure of 5a
















































Scheme 1. Synthesis of sultam 5a from: (a) the two-component reaction of 3a and
4a, and (b) the three-component reaction of 1a, 2a, and 4a.
6614 M. Ghandi et al. / Tetrahedron Letters 52 (2011) 6613–6615We next examined several primary amines 1a–e, in the
coupling of b-ketoester 2a with styrenesulfonyl chloride (4a) using
our one-pot method (Table 1). Whereas linear amines afforded the
sultams in good yields (entries 1, 2 and 5, Table 1), lower yieldsTable 1


















1a-e 2a 4a 5a-e
Entry R1 Time (h) Product Yield (%)
1 Propyl 12 5a 76
2 Butyl 12 5b 72
3 sec-Butyl 24 5c 42
4 Cyclohexyl 24 5d 35
5 Benzyl 16 5e 73
Figure 2. ORTEP diagramwere obtained with branched amines (entries 3 and 4, Table 1).
Compared to linear amines, sec-butylamine, and cyclohexylamine
with increased steric crowding about the nitrogen atom would
be expected to react more slowly with styrenesulfonyl chloride
(4a).
To further explore the scope of this reaction, several 1,3-dicar-
bonyl compounds 2a–c and substituted styrenesulfonyl chlorides
4a–c were examined (Scheme 2, Table 2). The analytical data
including IR, 1H NMR, and 13C NMR spectra of the products 5f–o
were in agreement with the proposed structures.19 Conﬁrmation
of the product structure was obtained by single crystal X-ray dif-
fraction of d-sultam 5m (Fig. 2).20
The results shown in Table 2 reveal that dicarbonyl compounds
either in the form of b-ketoesters or 1,3-diketones, and unsubsti-
tuted or substituted styrenesulfonyl chlorides with electron-with-
drawing groups were tolerated.
In conclusion, a variety of sultams 5a–o were synthesized in
moderate to good yields via one-pot, three-component reactions
of 1,3-dicarbonyl compounds, amines and substituted1a-e 2a-c 4a-c 5f-o
R3
Scheme 2. Synthesis of sultams 5f–o via the condensation of various amines, 1,3-
dicarbonyl compounds and styrenesulfonyl chlorides.
Table 2
Reactions of various amines 1a–e, 1,3-dicarbonyl compounds 2a–c and styrenesulfo-
nyl chlorides 4a–c to afford sultams 5f–o
Entry R1 R2 R3 Time (h) Product Yield (%)
1 Propyl OEt Cl 12 5f 83
2 Butyl OEt Cl 12 5g 67
3 sec-Butyl OEt Cl 24 5h 36
4 Cyclohexyl OEt Cl 24 5i 37
5 Benzyl OEt Cl 12 5j 78
6 H OMe H 24 5k 86
7 H OMe Cl 24 5l 42
8 Propyl Me Br 12 5m 77
9 Butyl Me H 12 5n 66
10 Butyl Me Cl 12 5o 62
of compound 5m.
M. Ghandi et al. / Tetrahedron Letters 52 (2011) 6613–6615 6615styrenesulfonyl chlorides. The six-membered sultams were pre-
sumably obtained via N-sulfonylation—intramolecular Michael
addition sequences.
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